Alpha 2.0
Login Register
» Articles » PMID: 31977412

New Treatment for Cystic Fibrosis

Overview
Journal Am J Nurs
Specialty Nursing
Date 2020 Jan 25
PMID 31977412
Citations 3
Authors
Diane S Aschenbrenner
Affiliations
Soon will be listed here.
Citing Articles

The impact of elexacaftor/tezacaftor/ivacaftor on cystic fibrosis health-related quality of life and decision-making about daily treatment regimens: a mixed methods exploratory study.

Basile M, Polo J, Henthorne K, DeCelie-Germana J, Galvin S, Wang J Ther Adv Chronic Dis. 2024; 15:20406223241264477.

PMID: 39091508 PMC: 11292704. DOI: 10.1177/20406223241264477.

Educational Needs and Preferences for Patient-Centered Outcomes Research in the Cystic Fibrosis Community: Mixed Methods Study.

Godfrey E, Kazmerski T, Brown G, Thayer E, Mentch L, Pam M JMIR Form Res. 2021; 5(3):e24302.

PMID: 33661127 PMC: 7974760. DOI: 10.2196/24302.

Cystic Fibrosis: Overview of the Current Development Trends and Innovative Therapeutic Strategies.

Almughem F, Aldossary A, Tawfik E, Alomary M, Alharbi W, Alshahrani M Pharmaceutics. 2020; 12(7).

PMID: 32630625 PMC: 7407299. DOI: 10.3390/pharmaceutics12070616.